Navigation Links
Swiss Biotech Gnubiotics, Announces Global Launch of GNU100 the First Microbiome Specialty Ingredient for Companion Animal Gut Health
Date:4/12/2019

Gnubiotics Sciences SA is a Swiss biotech company pioneering the development of products from complex microbiota accessible carbohydrates (MACs) as specialty ingredients for the global animal and human nutrition markets.

Gnubiotics announced its listing in the EU Feed Materials Register and commercial launch of its first-in class microbiome modulating prebiotic GNU100, for companion animal gut health. Gnubiotics’ GNU100 MAC is registered in Europe as an oligosaccharide-peptide complex with the objective to enhance microbiota restoration. As a result of its activity on specific commensals in the microbiome, GNU100 will also be studied to act as a weight control modulator.

GNU100 comprises of at least 30 different oligosaccharide structures that are functional mimics of Human Milk Oligosaccharides (HMOs). HMOs are oligosaccharides found naturally in animal and human breast milk and are key to the early development and maintenance of the immune system.

At Vitafoods Europe, Gnubiotics will host a presentation by Prof. Kelly Swanson of the University of Illinois-Urbana Champaign, titled “Modulatory Activity of Microbiota Accessible Carbohydrates” which will highlight GNU100 in vivo palatability data as well as the in vitro activity of GNU100 on key microbes beneficial to companion animal health Lactobacillus acidophilus, Akkermansia muciniphila and Bacteroides thetaiotaomicron.

“The global launch of GNU100 marks a milestone in our commitment to bringing the benefits of our pipeline of functional HMO mimics to companion animals,” said JP Kunz, CEO at Gnubiotics.

Through the combination of advanced high-precision chemistry and genomic technologies, Gnubiotics aims to expand nutritional solutions, to meet consumer expectations for effective, natural and healthier foods and supplements for their companion animal.

To learn more about how GNU100 can benefit your consumers, please visit Gnubiotics Sciences at Vitafoods Europe in Geneva Palexpo, May 7 – 9, 2019, at booth #K85
StartLab / Biopôle, Route de la Corniche, 5, Bat. SE-B Page 1 of 2 CH-1066 Epalinges

Media contact information – Gnubiotics Sciences SA. Jean Philippe Kunz, CEO Email: jpkunz(at)gnubiotics.com

Read the full story at https://www.prweb.com/releases/swiss_biotech_gnubiotics_announces_global_launch_of_gnu100_the_first_microbiome_specialty_ingredient_for_companion_animal_gut_health/prweb16240237.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Swiss cheese crystal, or high-tech sponge?
2. Jessica Wein Joins Lifecycle Biotechnologies As Marketing Strategist
3. Peer-Reviewed Paper in Frontiers in Bioengineering and Biotechnology Reveals that uBiome Has the Largest Patent Portfolio in the Microbiome Space
4. Lifecycle Biotechnologies Announces Promotion of Cindy Baptiste to Business Development Manager
5. Lifecycle Biotechnologies Releases Company Catalog
6. Lifecycle Biotechnologies Launches 100-Liter SAFEthread Drum
7. Avastus Opens New Vivarium to Serve the Preclinical Research Needs of Boston’s Biotech Community
8. Biotech Automation and FDA Validation Expert Superior Controls to Exhibit and Recruit at the ISPE Annual Premier One-Day Biopharmaceutical Show on September 26
9. Dickinson Wright Attorney Lance Anderson Named Pharmaceuticals and Biotechnology Practice Group Chair
10. William Muzek joins Lifecycle Biotechnologies as Business Development Manager
11. Venture Fund with Key Focus on Alzheimers Announces Investment in M3 Biotechnology and Its Drug Aimed at Regrowing Brain Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2020)... (PRWEB) , ... March 24, 2020 , ... ... are developing a CANARY ™ biosensor to detect the Novel SARS Coronavirus (SARS-CoV-2), ... for research purposes in May 2020 and validation data on the new SARS-CoV-2 ...
(Date:3/20/2020)... ... March 20, 2020 , ... OUHSC and Pure MHC ... the COVID-19 virus. The scientific team is led by William Hildebrand, Ph.D., whose expertise ... be working with Pure MHC, part of a family of biotechnology companies formed, funded ...
(Date:3/19/2020)... ... 17, 2020 , ... Shoreline Biome , a microbiome ... level, recently unveiled a convenient new solution for the generation of 16S and ... capabilities as the Shoreline Complete kit. It is a convenient solution for microbiome ...
Breaking Biology News(10 mins):
(Date:2/26/2020)... ... February 25, 2020 , ... Continuing its ... published the results of its safety assessment on the biotechnologically produced 3-Fucolsyllactose (3-FL) ... human milk. These complex carbohydrates are indigestible and therefore function as a prebiotic ...
(Date:2/21/2020)... TORONTO (PRWEB) , ... February 21, 2020 , ... ... innovation to improve their manufacturing operations in order to adapt to new approaches ... keep up with the increasing demand for personalized medicine and therapies. But with ...
(Date:2/11/2020)... (PRWEB) , ... February 11, ... ... company) is pleased to announce the successful results from a long-term follow-up ... using the Inspan interspinous fixation device (INSPAN LLC). Unlike extension block design, ...
(Date:2/3/2020)... ... February 03, 2020 , ... Ovation ... Law Firm Travel, Technology Industry Travel and Biotech/Healthcare Industry Travel Indexes. , All ... illustrates the following statistics:, Average airfare price paid ...
Breaking Biology Technology: